Filing Details
- Accession Number:
- 0000950170-25-002813
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-01-07 16:00:06
- Reporting Period:
- 2025-01-03
- Accepted Time:
- 2025-01-07 16:00:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1800315 | Galecto Inc. | GLTO | Pharmaceutical Preparations (2834) | 371957007 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1808248 | Lori Firmani | Ole Maaloes Vej 3 C/O Galecto, Inc. Copenhagen N G7 G7 DK-2200 | Interim Cfo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-01-03 | 726 | $0.00 | 726 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-01-03 | 261 | $5.63 | 465 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2025-01-03 | 726 | $0.00 | 726 | $0.00 |
| Common Stock | Stock Option (right to buy) | Acquisiton | 2025-01-03 | 5,000 | $0.00 | 5,000 | $5.70 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,474 | No | 4 | M | Direct | ||
| 5,000 | 2035-01-03 | No | 4 | A | Direct |
Footnotes
- Each restricted stock unit ("RSU") represents the right to receive, at settlement, one share of common stock of the Issuer. This transaction represents the settlement of RSUs in shares of common stock on their scheduled vesting date.
- Shares sold to cover tax obligations in connection with the vesting of the RSUs listed in Table II. This sale is mandated by the Issuer's election under its 2020 Equity Incentive Plan and does not represent a discretionary trade by the Reporting Person.
- This award was granted on January 3, 2024. One-third of the RSUs subject to the award vested on January 3, 2025 and one-sixth of the RSUs subject to the award award will vest ratably every six months thereafter, assuming continued employment through the applicable vesting date.
- 25% of the shares subject to such option will vest and become exercisable on January 3, 2026 and the remainder of the shares vest in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.
Billionaire Hedge Funds
